Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by iTeos Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for iTeos Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for iTeos Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Rhoads Ann DDirector–Aug 29, 20250
Hallal DavidDirector0Aug 29, 20250
Gall MatthewChief Financial Officer0Aug 29, 20250
Detheux MichelChief Executive Officer0IndirectAug 29, 20250
Call MatthewChief Operating Officer0Aug 29, 20250
McGrath YvonneChief Scientific Officer0Aug 29, 20250
Lee David KDirector–Aug 29, 20250
Feltquate DavidChief Medical Officer0Aug 29, 20250
EcoR1 Capital, LLC10% Owner10,688,978IndirectMay 16, 20250
Gadicke AnsbertOther: Former 10% Owner3,452,797IndirectMay 15, 20250
MPM BioImpact LLCOther: Former 10% Owner3,452,797IndirectMay 15, 20250
UBS Oncology Impact Fund L.P.Other: Former 10% Owner3,452,797IndirectMay 15, 20250
Oncology Impact Fund (Cayman) Management L.P.Other: Former 10% Owner3,452,797IndirectMay 15, 20250
MPM Bioventures 2018, L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2018 GP LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2018 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
Evnin LukeOther: Former 10% Owner2,108,594IndirectMay 15, 20250
Foley ToddOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014, L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014 (B), L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM Asset Management Investors BV2014 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM Bioventures 2018 (B), L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM Asset Management Investors BV2018 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014 GP LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
Van Hauwermeiren TimothyDirector22,346May 14, 20250
Davis Aaron I.Director2,946,915Jun 13, 20240
Ho Tony WDirector–Jun 13, 20240
Iannone RobertDirector–Jun 13, 20240
DeSimone JillDirector–Jun 13, 20240
Lewis JosephOther: See remarks2,946,915May 14, 20240
Boxer Asset Management Inc.Other: See remarks2,946,915May 14, 20240
Boxer Capital, LLCOther: See remarks2,946,915May 14, 20240
RA Capital Healthcare Fund LPOther: Former 10% Owner2,545,510IndirectMay 14, 20240
Ra Capital Management, L.P.Other: Former 10% Owner2,545,510IndirectMay 14, 20240
Kolchinsky PeterOther: Former 10% Owner2,545,510IndirectMay 14, 20240
Shah Rajeev M.Other: Former 10% Owner2,545,510IndirectMay 14, 20240
DiRocco DerekDirector–Jun 15, 20230
Lager Joanne JenkinsChief Medical Officer0Mar 10, 20230
Biniszkiewicz DetlevDirector0Jun 10, 20220
Roden MatthewDirector–Jun 10, 20220
MVA Investors, LLC10% Owner0Jan 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 11, 2025 (view filing)Jun 9-102 daysDetheux MichelChief Executive OfficerSSale−16.8K$10.03−$168.4K−11.0%135.9K after2 lots10b5-1
Jun 11, 2025 (view filing)Jun 9-102 daysDetheux MichelChief Executive OfficerSSale−87.8K$10.02−$879.8K−100.0%0 after2 lots10b5-1
Jun 6, 2025 (view filing)Jun 4-62 daysDetheux MichelChief Executive OfficerSSale−25.2K$10.15−$255.9K−15.6%135.9K after3 lots10b5-1
Jun 6, 2025 (view filing)Jun 4-62 daysDetheux MichelChief Executive OfficerSSale−131.6K$10.15−$1.34M−100.0%0 after3 lots10b5-1
Jun 6, 2025 (view filing)Jun 4-62 daysHallal DavidDirectorSSale−114.7K$10.15−$1.16M−100.0%0 after3 lots10b5-1
May 16, 2025 (view filing)May 14-152 daysEcoR1 Capital, LLC10% OwnerPPurchase+4.96M$7.80+$38.7M+86.5%10.7M after2 lots
May 15, 2025 (view filing)5:34 PM ETMay 132 daysGadicke Ansbert and 3 othersOther: Former 10% OwnerSSale−1.03M$8.06−$8.32M−23.0%3.45M after
May 15, 2025 (view filing)5:33 PM ETMay 132 daysMPM Bioventures 2018, L.P. and 2 othersOther: Former 10% OwnerSSale−630.2K$8.06−$5.08M−23.0%2.11M afterDuplicate filing
May 15, 2025 (view filing)5:32 PM ETMay 132 daysEvnin Luke and 8 othersOther: Former 10% OwnerSSale−630.2K$8.06−$5.08M−23.0%2.11M after
Nov 19, 2024 (view filing)Nov 19Same dayGall MatthewChief Financial OfficerPPurchase+5.00K$7.73+$38.6K+8.3%65.4K after
May 14, 2024 (view filing)9:06 PM ETMay 104 daysRA Capital Healthcare Fund LP and 3 othersOther: Former 10% OwnerPPurchase+5.71M$17.50+$100.0M–5.71M afterDerivative
Oct 12, 2023 (view filing)Oct 12Same dayGall MatthewChief Financial OfficerPPurchase+5.00K$8.37+$41.9K+34.7%19.4K after
Aug 25, 2023 (view filing)9:28 PM ETAug 232 daysLewis Joseph and 3 othersOther: See remarksSSale−350.0K$16.26−$5.69M−16.2%1.80M after3 lots
Jun 10, 2022 (view filing)Jun 8-92 daysHallal DavidDirectorSSale−29.6K$20.17−$597.2K−100.0%0 after4 lots
May 11, 2022 (view filing)May 9-112 daysDavis Aaron I.DirectorSSale−663.0K$21.04−$14.0M−23.5%2.15M after6 lots
May 2, 2022 (view filing)Apr 28-May 24 daysDavis Aaron I.DirectorSSale−375.0K$27.32−$10.2M−11.7%2.82M after5 lots
Apr 19, 2022 (view filing)Apr 181 dayDetheux MichelChief Executive OfficerSSale−11.5K$31.87−$366.5K−30.5%26.3K after2 lots
Mar 24, 2022 (view filing)Mar 22-232 daysDavis Aaron I.DirectorPPurchase+50.0K$32.51+$1.63M+1.6%3.19M after4 lots
Mar 22, 2022 (view filing)Mar 22Same dayDetheux MichelChief Executive OfficerSSale−18.4K$34.17−$630.0K−41.2%26.3K after4 lots
Mar 18, 2022 (view filing)9:00 PM ETMar 171 dayLewis Joseph and 2 others10% OwnerSSale−575.2K$35.25−$20.3M−15.5%3.14M after
Mar 14, 2022 (view filing)Mar 113 daysLager Joanne JenkinsChief Medical OfficerSSale−3.50K$36.01−$126.0K−100.0%0 after
Mar 2, 2022 (view filing)Mar 11 dayMcGrath YvonneChief Scientific OfficerSSale−10.0K$36.76−$367.6K−100.0%0 after
Feb 24, 2022 (view filing)Feb 231 dayDetheux MichelChief Executive OfficerSSale−14.5K$34.34−$497.9K−29.5%34.7K after2 lots
Feb 14, 2022 (view filing)Feb 113 daysLager Joanne JenkinsChief Medical OfficerSSale−3.50K$35.85−$125.5K−100.0%0 after2 lots
Jan 26, 2022 (view filing)Jan 251 dayDetheux MichelChief Executive OfficerSSale−14.5K$35.68−$517.4K−22.8%49.2K after2 lots
Jan 18, 2022 (view filing)Jan 144 daysLager Joanne JenkinsChief Medical OfficerSSale−3.50K$39.32−$137.6K−100.0%0 after2 lots
Jan 6, 2022 (view filing)4:13 PM ETJan 4-52 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−146.7K$42.58−$6.25M−5.1%2.74M after5 lotsDuplicate filing
Jan 6, 2022 (view filing)4:12 PM ETJan 4-52 daysEvnin Luke and 8 others10% OwnerSSale−146.7K$42.58−$6.25M−5.1%2.74M after5 lots
Jan 6, 2022 (view filing)4:12 PM ETJan 4-52 daysGadicke Ansbert and 3 others10% OwnerSSale−245.5K$42.58−$10.5M−5.2%4.48M after5 lots
Jan 5, 2022 (view filing)9:20 PM ETJan 3-42 daysBoxer Capital, LLC and 4 othersDirector, 10% OwnerSSale−700.0K$46.54−$32.6M−100.0%0 after14 lots
Jan 4, 2022 (view filing)Jan 31 dayLager Joanne JenkinsChief Medical OfficerSSale−7.00K$51.90−$363.3K−100.0%0 after
Jan 4, 2022 (view filing)Jan 31 dayBiniszkiewicz DetlevDirectorSSale−3.50K$51.90−$181.7K−100.0%0 after
Dec 28, 2021 (view filing)Dec 271 dayGall MatthewChief Financial OfficerSSale−5.00K$46.45−$232.3K−25.7%14.4K after
Dec 22, 2021 (view filing)Dec 20-222 daysDetheux MichelChief Executive OfficerSSale−44.5K$44.54−$1.98M−41.1%63.7K after7 lots
Dec 22, 2021 (view filing)Dec 202 daysHallal DavidDirectorSSale−50.0K$43.57−$2.18M−100.0%0 after
Dec 17, 2021 (view filing)Dec 17Same dayLager Joanne JenkinsChief Medical OfficerSSale−7.00K$41.00−$287.0K−100.0%0 after
Dec 10, 2021 (view filing)Dec 10Same dayLager Joanne JenkinsChief Medical OfficerSSale−3.50K$34.50−$120.8K−100.0%0 after
Dec 7, 2021 (view filing)6:36 PM ETDec 3-74 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−49.8K$33.73−$1.68M−1.7%2.89M after9 lotsDuplicate filing
Dec 7, 2021 (view filing)6:35 PM ETDec 3-74 daysEvnin Luke and 8 others10% OwnerSSale−49.8K$33.73−$1.68M−1.7%2.89M after9 lots
Dec 7, 2021 (view filing)6:33 PM ETDec 3-74 daysGadicke Ansbert and 3 others10% OwnerSSale−83.4K$33.73−$2.81M−1.7%4.73M after9 lots
Dec 2, 2021 (view filing)6:56 PM ETNov 30-Dec 22 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−83.5K$34.47−$2.88M−2.8%2.94M after7 lotsDuplicate filing
Dec 2, 2021 (view filing)6:53 PM ETNov 30-Dec 22 daysEvnin Luke and 8 others10% OwnerSSale−83.5K$34.47−$2.88M−2.8%2.94M after7 lots
Dec 2, 2021 (view filing)6:53 PM ETNov 30-Dec 22 daysGadicke Ansbert and 3 others10% OwnerSSale−139.8K$34.47−$4.82M−2.8%4.81M after7 lots
Nov 30, 2021 (view filing)4:57 PM ETNov 26-294 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−23.0K$35.18−$810.8K−0.8%3.02M after4 lotsDuplicate filing
Nov 30, 2021 (view filing)4:53 PM ETNov 26-294 daysEvnin Luke and 8 others10% OwnerSSale−23.0K$35.18−$810.8K−0.8%3.02M after4 lots
Nov 30, 2021 (view filing)4:49 PM ETNov 26-294 daysGadicke Ansbert and 3 others10% OwnerSSale−38.6K$35.18−$1.36M−0.8%4.95M after4 lots
Nov 24, 2021 (view filing)6:38 PM ETNov 22-242 daysGadicke Ansbert and 3 others10% OwnerSSale−129.6K$36.61−$4.74M−2.5%4.99M after7 lots
Nov 24, 2021 (view filing)6:35 PM ETNov 22-242 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−77.5K$36.61−$2.84M−2.5%3.04M after7 lotsDuplicate filing
Nov 24, 2021 (view filing)6:34 PM ETNov 22-242 daysEvnin Luke and 8 others10% OwnerSSale−77.5K$36.61−$2.84M−2.5%3.04M after7 lots
Nov 24, 2021 (view filing)Nov 231 dayDetheux MichelChief Executive OfficerSSale−14.5K$36.08−$523.2K−15.6%78.2K after